Cargando...

How will evolving future therapies and strategies change how we position the use of biologics in moderate to severely active inflammatory bowel disease

Several biologic agents have been added to our armamentarium of treatment options for moderate to severely active IBD, and this number is expected to only increase in the near future. With our growing understanding of disease mechanisms and pharmacokinetics, we are now able to target several mechani...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Inflamm Bowel Dis
Autores principales: Dulai, Parambir S., Singh, Siddharth, Vande Casteele, Niels, Boland, Brigid S., Sandborn, William J.
Formato: Artigo
Lenguaje:Inglês
Publicado: 2016
Materias:
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5953904/
https://ncbi.nlm.nih.gov/pubmed/26835982
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MIB.0000000000000661
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!